Covered recipient · General Payments record
JENNIFER JEAN THOMAS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2025
$699.70
- Reported across 37 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $290.77 | 15 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $79.58 | 5 |
| Novo Nordisk AS | $62.47 | 3 |
| Astellas Pharma US Inc | $50.92 | 2 |
| Reprise Biomedical, Inc. | $24.27 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $23.07 | 1 |
| Acerta Pharma LLC | $18.79 | 1 |
| Alexion Pharmaceuticals, Inc. | $17.98 | 1 |
| Lilly USA, LLC | $13.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $17.98 | 08/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202960956 | CMS |
| Amgen Inc. | $14.56 | 04/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227064989 | CMS |
| Amgen Inc. | $18.00 | 05/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228694248 | CMS |
| Amgen Inc. | $14.31 | 07/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227064987 | CMS |
| Amgen Inc. | $16.66 | 09/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228694250 | CMS |
| Amgen Inc. | $16.05 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228694252 | CMS |
| Astellas Pharma US Inc | $26.04 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238674971 | CMS |
| Astellas Pharma US Inc | $24.88 | 12/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238596154 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.79 | 11/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206320278 | CMS |
| Lilly USA, LLC | $13.69 | 08/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186698505 | CMS |
| Novo Nordisk Inc | $14.59 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188336278 | CMS |
| Novo Nordisk Inc | $30.25 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188144091 | CMS |
| Novo Nordisk Inc | $17.63 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188266228 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $23.07 | 08/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181725145 | CMS |
| Reprise Biomedical, Inc. | $24.27 | 12/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1178586672 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.